Ventripoint Diagnostics Ltd

Ventripoint is a pioneer in the application of Artificial Intelligence to cardiac imaging. Ventripoint's unique technology uses an AI approach known as Knowledge-Based Reconstruction (KBR) to create cardiac MRI-accurate 3D heart models. These models are used to make applications that help diagnose and monitor heart disease, a leading cause of death worldwide. VMS+, our first application, turns standard 2D echo scans of the heart into cardiac MRI-accurate volumetric measurements. This enables more patients to receive the care they require. VMS+ 3D allows a full functional assessment of all four chambers of the heart from a single 3D echo scan. The Company has developed a suite of applications for all major heart diseases and is actively commercializing the approach to improve cardiac care.(TSXV:VPT, OTCQB:VPTDF)